http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2898836-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42dcb8afd289e295b65f450020cbfdb4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-88 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 |
| filingDate | 2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e163978f60ff0f4ca235ad77210f48c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7edcff7a708dac03a425072dbf57340b |
| publicationDate | 2022-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2898836-T3 |
| titleOfInvention | 2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof |
| abstract | A compound according to formula (1): **(See formula)** or a reduced form thereof or a pharmaceutically acceptable salt thereof, wherein R1 and R2 are each independently (1) a hydrogen atom, (2) an optionally substituted C1-6 alkyl group, an optionally substituted C2-6 alkenyl group, or an optionally substituted C2-6 alkynyl group, (3) an optionally substituted C3-10 alicyclic hydrocarbon group, wherein the group may contain one or more unsaturated bonds, (4) an optionally substituted 3- to 8-membered heterocyclic group, wherein the group may contain one or more unsaturated bonds and a carbon atom in the ring of the group is bonded to the nitrogen atom to which they are attached R1 and R2, (5) an optionally substituted C6-10 aryl group or (6) an optionally substituted 5 to 12 membered monocyclic or polycyclic heteroaryl group, with the proviso that in the group, a carbon atom in its ring is bonded to the nitr atom The gen to which R1 and R2 are attached or R1 and R2 may be taken together with the nitrogen atom to which they are attached to form a 3- to 8-membered nitrogen-containing heterocycle, wherein the heterocycle may contain one or more unsaturated bonds. and R3 is (1) an optionally substituted C6-10 aryl group or (2) an optionally substituted 5- to 12-membered monocyclic or polycyclic heteroaryl group, with the proviso that in the group, a carbon atom in its ring is bonded to the carbon atom to which R3 is attached. |
| priorityDate | 2016-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 264.